N6-methyladenosine regulators in hepatocellular carcinoma: investigating the precise definition and clinical applications of biomarkers
Abstract Background Accurately identifying effective biomarkers and translating them into clinical practice have significant implications for improving clinical outcomes in hepatocellular carcinoma (HCC). In this study, our objective is to explore appropriate methods to improve the accuracy of bioma...
Saved in:
| Main Authors: | Xiaokai Yan, Yao Qi, Xinyue Yao, Lulu Yin, Hao Wang, Ji Fu, Guo Wan, Yanqun Gao, Nanjing Zhou, Xinxin Ye, Xiao Liu, Xing Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Biology Direct |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13062-024-00554-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01) -
Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
by: Dongjing Zhang, et al.
Published: (2025-01-01) -
Targeting m6A methylation for early diagnosis and precision medicine in hepatocellular carcinoma
by: Qing-Kang Zheng, et al.
Published: (2025-07-01) -
Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01) -
APPROACHES TO THE DEFINITION OF ENTREPRENEURSHIP THROUGH THE PRISM OF ECONOMIC THEORY
by: M. R. Tashtamirov, et al.
Published: (2020-12-01)